Unknown

Dataset Information

0

The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.


ABSTRACT: AIM:The objective of this study was to evaluate the prognostic value of ARID1A, p53, p21, p16 and ß-Catenin in endometrioid and clear cell ovarian and endometrial carcinomas. MATERIALS AND METHODS:97 tumors were available for analysis of ARID1A, p53, p21, p16 and ß-Catenin with the techniques of tissue microarray and immunohistochemistry. 32 were ovarian carcinomas and 65 were endometrial carcinomas. RESULTS:Endometrioid ovarian carcinomas showed negative staining for ARID1A (a) and p21 (b), aberrant expression of p53 (c) and p16 (d) and ß-Catenin positive nuclear expression (e) respectively in 19% (a), 100% (b), 28.6% (c), 52.4% (d) and 4.8% (e) of all cases. In the group of clear cell ovarian carcinomas it was 63.6% (a), 100% (b), 81.8% (c), 54.5% (d) and 0% (e). For endometrioid uterine carcinomas it was 75.7% (a), 94.9% (b), 30.5% (c), 52.1% (d) and 6.8% (e) and for clear cell uterine carcinomas it was 8.6% (a), 100% (b), 50% (c), 100% (d) and 0% (e). Survival analysis showed that negative expression of ARID1A, p53 aberrant expression and ß-Catenin nuclear positive staining are independent negative prognosticators in both, clear cell and endometrioid carcinoma, regardless of ovarian or uterine origin. Cox-Regression analysis showed them again as negative prognostic factors. Furthermore, we found a significant correlation between ARID1A and ß-Catenin expression in endometrioid uterine tumors. CONCLUSION:The analyzed gynaecological carcinoma showed a distinct expression scheme of proteins that are associated with tumor suppression. We may conclude that ARID1A, p53 and ß-Catenin are the strongest prognostic factors by analyzing a subgroup of tumor suppressor genes in clear cell and endometrioid subtypes of ovarian and endometrial cancer and may be used along with traditional morphological and clinical characteristics for prognosis.

SUBMITTER: Heckl M 

PROVIDER: S-EPMC5815611 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.

Heckl Marlene M   Schmoeckel Elisa E   Hertlein Linda L   Rottmann Miriam M   Jeschke Udo U   Mayr Doris D  

PloS one 20180216 2


<h4>Aim</h4>The objective of this study was to evaluate the prognostic value of ARID1A, p53, p21, p16 and ß-Catenin in endometrioid and clear cell ovarian and endometrial carcinomas.<h4>Materials and methods</h4>97 tumors were available for analysis of ARID1A, p53, p21, p16 and ß-Catenin with the techniques of tissue microarray and immunohistochemistry. 32 were ovarian carcinomas and 65 were endometrial carcinomas.<h4>Results</h4>Endometrioid ovarian carcinomas showed negative staining for ARID1  ...[more]

Similar Datasets

| S-EPMC7264300 | biostudies-literature
| S-EPMC4939882 | biostudies-literature
| S-EPMC3460070 | biostudies-literature
2022-10-31 | GSE165239 | GEO
| S-EPMC4488511 | biostudies-literature
| S-EPMC3077471 | biostudies-literature
| S-EPMC4845188 | biostudies-other
| S-EPMC3787317 | biostudies-literature
| S-EPMC8068058 | biostudies-literature
| S-EPMC10643375 | biostudies-literature